Search
for

    Did you mean Endocrine Therapy-Induced Alopecia?
    Glossary Endocrine Therapy-Induced Alopecia

    hair loss caused by treatments that alter hormone levels

    Endocrine Therapy-Induced Alopecia, also known as Hormone Therapy-Induced Alopecia, refers to hair loss that occurs as a side effect of treatments that alter hormone levels, commonly used in managing cancers like breast or prostate cancer. These therapies, such as tamoxifen or aromatase inhibitors, disrupt the normal hormonal balance, leading to thinning hair or baldness.

    Related Terms

    Research 10 of 1000+

    1. Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot Study Dermatologic Surgery · 2025
    2. Minoxidil for Endocrine Therapy–Induced Alopecia in Women With Breast Cancer—Saint Agatha’s Blessing? JAMA Dermatology · 2018 · 9 citations
    3. Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer JAMA Dermatology · 2018 · 67 citations
    4. Approaches to management of endocrine therapy–induced alopecia in breast cancer patients Supportive Care in Cancer · 2025 · 1 citations
    5. 51895 Interim Analysis of Platelet-Rich Plasma (PRP) Treatment for Endocrine Therapy-Induced Alopecia (EIA) and Permanent Chemotherapy-Induced Alopecia (pCIA) in Breast Cancer Patients: A Randomized Controlled Trial Journal of the American Academy of Dermatology · 2024
    6. 0478 Outcomes of oral dutasteride and oral minoxidil for treating endocrine therapy-induced alopecia from breast cancer treatment: A case series Journal of Investigative Dermatology · 2025
    7. Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study Journal of The American Academy of Dermatology · 2022
    8. Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies Cutis · 2021 · 2 citations
    9. Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure Clinical and Experimental Dermatology · 2015 · 5 citations
    10. CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients. Journal of Clinical Oncology · 2019 · 4 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →